AIX-EN-PROVENCE, France--(BUSINESS WIRE)--SuperSonic Imagine, the innovative ultrasound imaging company, today announced that it has been selected by the Mid-Atlantic Group Network of Shared Services (MAGNET) to provide its Participating Healthcare Facilities with the most advanced ultrasound technology on the market. MAGNET was created to develop contracts on behalf of its Healthcare Facilities in the niche market of capital equipment to provide the best quality patient care at the best possible pricing.
“We are extremely pleased to have this three year agreement in place with SuperSonic Imagine to offer the Aixplorer® MultiWave™ Ultrasound system to our Participating Healthcare Facilities,” said Steven R. Duke, Vice President and Chief Operating Officer for MAGNET. “SuperSonic Imagine has a strong reputation for being an ultrasound industry leader and innovator, that brings important, clinically focused imaging solutions to healthcare providers. Their revolutionary software-based ultrasound imaging system has a wide range of clinical applications which bring the greatest utility for MAGNET Participating Healthcare Facilities.”
On the market since 2009, the Aixplorer MultiWave Ultrasound System’s clinical applications include Vascular, Breast and 3D Breast, Abdomen, Liver, Thyroid, Musculoskeletal, Gynecology, and Prostate. The system is in a class of its own with a software-based architecture that industry analysts believe has ushered in a new era in ultrasound imaging. No longer held back by hardware constraints, an ultra-fast software platform gives the Aixplorer the capability of visualizing fine detail never seen before. Aside from exceptional gray scale quality, the foundation of ultrasound imaging, Aixplorer offers true innovation not found on conventional systems. The first major breakthrough born of this ultra-rapid software is ShearWave™ Elastography, which reveals local, real-time true tissue stiffness in a reproducible, user-skill independent manner. This technology, clinically proven through a rigorous multi-center global study, uses the combination of shear waves and ultrasound waves to image tissue elasticity, a technique never before possible due to hardware limitations. The second major innovation made possible through its ultra-fast platform, is UltraFast™ Doppler, a mode that combines Color Flow Imaging with Pulsed Wave Doppler. Workflow and diagnostic confidence are significantly improved with blood flow data clips that render extremely quick color frame rates (up to 200Hz), high quality flow information without compromises and full spectral Doppler analysis with multiple sample volumes instantly.
“MAGNET’s drive to provide the best quality for the best price has always been our goal as well at SuperSonic Imagine,” said CEO Jacques Souquet. “We are happy to be a part of the MAGNET network and to furnish their Participating Healthcare Facilities with ultrasound technology that provides extremely clear image quality with unprecedented innovation to address their clinical challenges.”
About SuperSonic Imagine
Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is an innovative, international company specializing in ultrasound medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with a unique ultrasound imaging technology, called MultiWave™ Technology. This technology allows Aixplorer® to be the only ultrasound system that images two types of waves to better characterize tissue; an ultrasound wave to ensure impeccable image quality and a shear wave, ShearWave™ Elastography, to compute and display true tissue stiffness in real time by acquiring images nearly 200 times faster than conventional systems.
ShearWave™ Elastography and UltraFast™ Doppler made possible by Aixplorer’s software technology, allow physicians to visualize and analyze in real-time, thanks to a reliable, reproducible and extremely rapid process, the stiffness and vascularization of tissue in order to significantly improve the detection and characterization of numerous pathologies. The company has developed many clinical applications, including for the breast, thyroid, liver and prostate. In 2009, SuperSonic Imagine was granted 510(k) clearance by the Food and Drug Administration in the United States and CE mark in Europe for the marketing of Aixplorer®. SuperSonic Imagine has an installed base of 383 Aixplorers in over 50 countries as of March 31, 2012.
Distribution agreements have been signed with prestigious companies such as Hologic (Nasdaq: HOLX) for the breast market in the U.S.A. and Canon (NYSE: CAJ) for Japan.
SuperSonic Imagine holds the exclusive right, title and interest to 28 international patents and submissions in diagnostic imaging and therapy applications.
For more information about SuperSonic Imagine, please go to www.supersonicimagine.com.